Atara Biotherapeutics Inc carries a market capitalization of 94.41M, placing it among publicly traded companies globally.
| Market Cap | 94.41M |
| Enterprise Value | N/A |
Atara Biotherapeutics Inc's stock has gained approximately 23.73081% over the past 52 weeks. The 50-day moving average sits at 0.72, while the 200-day moving average is 1.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | 23.73081% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.30 |
| Average Volume (20 Days) | N/A |
Atara Biotherapeutics Inc's most recent stock split took place on June 20, 2024 with a 25:1 split ratio.
| Last Split Date | 6/20/2024 |
| Split Ratio | 25:1 |